Live Breaking News & Updates on Nasdaq Global Market Under Ticker

Stay updated with breaking news from Nasdaq global market under ticker. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

GBS Inc. Announces Pricing of Initial Public Offering


GBS Inc. Announces Pricing of Initial Public Offering
Will Trade on the Nasdaq Global Market Under Ticker “GBS”
NEW YORK, Dec. 22, 2020 (GLOBE NEWSWIRE) GBS Inc. (the “Company”) (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic testing in the hands of patients and their primary health practitioners at point of care, today announced the pricing of its initial public offering of 1,270,589 units at a public offering price of $17.00 per unit. Each unit will immediately separate into (a) one share of the Company’s common stock (or, at the purchaser’s election, one share of Series B Convertible Preferred Stock), (b) one Series A warrant (the “Series A Warrants”) to purchase one share of the Company’s common stock at an exercise price equal to $8.50 per share exercisable until the 5 ....

United States , Boca Raton , Jeremy Feffer , Exchange Commission , While The Company , Prospectus Department , Lifesci Advisors , Company Nasdaq , Dawson James Securities Inc , Gbs Inc , Will Trade , Nasdaq Global Market Under Ticker , Seriesb Convertible Preferred Stock , Seriesb Warrants , James Securities , Nasdaq Global Market , Dawson James Securities , Biosensor Platform , Sci Advisors , ஒன்றுபட்டது மாநிலங்களில் , போகா ரேடோந் , பரிமாற்றம் தரகு , போது தி நிறுவனம் , ப்ரோஸ்பெக்டஸ் துறை , நிறுவனம் நாஸ்டாக் , டாசன் ஜேம்ஸ் பத்திரங்கள் இன்க் ,

UPDATE - GBS Inc. Announces Pricing of $21.6 Million Initial Public Offering


UPDATE – GBS Inc. Announces Pricing of $21.6 Million Initial Public Offering
Will Trade on the Nasdaq Global Market Under Ticker “GBS”
NEW YORK, Dec. 23, 2020 (GLOBE NEWSWIRE) GBS Inc. (the “Company”) (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic testing in the hands of patients and their primary health practitioners at point of care, today announced the pricing of its initial public offering of 1,270,589 units at a public offering price of $17.00 per unit. Each unit will immediately separate into (a) one share of the Company’s common stock (or, at the purchaser’s election, one share of Series B Convertible Preferred Stock), (b) one Series A warrant (the “Series A Warrants”) to purchase one share of the Company’s common stock at an exercise price equal to $8.50 per share exercisable until the 5 ....

United States , Boca Raton , Jeremy Feffer , Exchange Commission , While The Company , Prospectus Department , Lifesci Advisors , Company Nasdaq , Dawson James Securities Inc , Gbs Inc , Will Trade , Nasdaq Global Market Under Ticker , Seriesb Convertible Preferred Stock , Seriesb Warrants , James Securities , Nasdaq Global Market , Dawson James Securities , Biosensor Platform , Sci Advisors , ஒன்றுபட்டது மாநிலங்களில் , போகா ரேடோந் , பரிமாற்றம் தரகு , போது தி நிறுவனம் , ப்ரோஸ்பெக்டஸ் துறை , நிறுவனம் நாஸ்டாக் , டாசன் ஜேம்ஸ் பத்திரங்கள் இன்க் ,